Abstract
Objective: Present a review about the use of mechanical pulmonary ventilation in Hypertension Pulmonary Persistent Neonatal (HPPN), the conventional mode and the indication of high-frequency oscillatory ventilation (HFOV). Also present other approaches, such as therapeutics use of exogenous surfactant, inhaled nitric oxide, phosphodiesterases inhibitors and extracorporeal membrane oxygenation. Data Source: It has been used in articles obtained in the Pub Med, Medline, Cochrane BVS, databases, in which there are topics about mechanical ventilation in Hypertension Pulmonary Persistent Neonatal and others treatments used in the newborn with HPPN. Conclusion: The effective treatments used in HPPN are a conventional, not very aggressive ventilatory strategy; HFOV; inhaled nitric oxide and vasodilators medications that act on the lungs rather than on the whole system, and, in newborns that do not respond to these treatments, the use of extracorporeal membrane oxygenation.
Keywords: Mechanical ventilation, hypertension pulmonary persistent neonatal, exogenous surfactant, nitric oxide, phosphodiesterases inhibitors, vasoreactivity, PFC syndrome, high-frequency oscillatory ventilation, coarctation of the aorta, meconium aspiration syndrome
Current Respiratory Medicine Reviews
Title: Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn
Volume: 8 Issue: 1
Author(s): Maria Esther Jurfest Ceccon and Werther Brunow de Carvalho
Affiliation:
Keywords: Mechanical ventilation, hypertension pulmonary persistent neonatal, exogenous surfactant, nitric oxide, phosphodiesterases inhibitors, vasoreactivity, PFC syndrome, high-frequency oscillatory ventilation, coarctation of the aorta, meconium aspiration syndrome
Abstract: Objective: Present a review about the use of mechanical pulmonary ventilation in Hypertension Pulmonary Persistent Neonatal (HPPN), the conventional mode and the indication of high-frequency oscillatory ventilation (HFOV). Also present other approaches, such as therapeutics use of exogenous surfactant, inhaled nitric oxide, phosphodiesterases inhibitors and extracorporeal membrane oxygenation. Data Source: It has been used in articles obtained in the Pub Med, Medline, Cochrane BVS, databases, in which there are topics about mechanical ventilation in Hypertension Pulmonary Persistent Neonatal and others treatments used in the newborn with HPPN. Conclusion: The effective treatments used in HPPN are a conventional, not very aggressive ventilatory strategy; HFOV; inhaled nitric oxide and vasodilators medications that act on the lungs rather than on the whole system, and, in newborns that do not respond to these treatments, the use of extracorporeal membrane oxygenation.
Export Options
About this article
Cite this article as:
Esther Jurfest Ceccon Maria and Brunow de Carvalho Werther, Ventilatory Support in Persistent Pulmonary Hypertension of the Newborn, Current Respiratory Medicine Reviews 2012; 8 (1) . https://dx.doi.org/10.2174/157339812798868834
DOI https://dx.doi.org/10.2174/157339812798868834 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Potential Role of Antioxidants in Metabolic Syndrome
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomarkers Pleiotropic Effects of Nifedipine on Atherosclerosis
Current Pharmaceutical Design Endothelial Dysfunction: Methods of Assessment and Application to Hypertension
Current Pharmaceutical Design The Role of Adipokines in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Pharmacokinetics and Metabolism of Diltiazem Following Multiple Doses:Comparing Normotensive Rat vs. Hypertensive Rat Models In vivo
Drug Metabolism Letters The Influence of Sex Hormones on Pulmonary Vascular Reactivity: Possible Vasodilator Therapies for the Treatment of Pulmonary Hypertension
Current Vascular Pharmacology Molecular Counting of Captopril by a Microfluidic Chip-Thermal Lens Microscopy System
Current Analytical Chemistry Neurovascular Mechanisms of Hypertension in Pregnancy
Current Neurovascular Research Aqueous Extract of Argania spinosa L. Fruits Ameliorates Diabetes in Streptozotocin-Induced Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Identification and Treatment of Patients with Early COPD
Current Respiratory Medicine Reviews Oral Chemotherapy in Elderly Women with Metastatic Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Evaluation of Echocardiographic Abnormalities in HIV Positive Patients Treated with Antiretroviral Medications
Infectious Disorders - Drug Targets Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke
Cardiovascular & Hematological Disorders-Drug Targets Recent Developments in Drug Design of NO-donor Hybrid Compounds
Mini-Reviews in Medicinal Chemistry Are the Pleiotropic Effects of Telmisartan Clinically Relevant?
Current Pharmaceutical Design Pharmacogenetic Study of CYP2C19 Variation and Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Atherothromboticrisk Patients in Thailand
Current Pharmacogenomics and Personalized Medicine Diabetic Retinopathy and Angiogenesis
Current Diabetes Reviews The Pathophysiological Basis of Carotid Baroreceptor Stimulation for the Treatment of Resistant Hypertension
Current Vascular Pharmacology Cardiac Dysfunction in Rats with Dietary-Induced Insulin Resistance Associated with Pharmacologically-induced Dyslipidemia
Current Pharmaceutical Design